BnJ Biopharma Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 16

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 5

BnJ Biopharma General Information

Description

Developer of an artificial intelligence-based biotechnology platform designed to accelerate the discovery and development of new drugs. The company leverages AI to pioneer drug development, from designing molecules to conducting in vitro and in vivo tests, driving the future of drug discovery with an integrated approach, enabling medical professionals to enhance the quality of life for patients and to shape a better future.

Contact Information

Website
www.bnjbio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 85, Songdo Gwahak-ro, Yeonsu-gu
  • Yonsei University International Campus Memorial Hall 2nd floor, Songdo-dong
  • Incheon
  • South Korea
+82
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 85, Songdo Gwahak-ro, Yeonsu-gu
  • Yonsei University International Campus Memorial Hall 2nd floor, Songdo-dong
  • Incheon
  • South Korea
+82

BnJ Biopharma Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BnJ Biopharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 07-Dec-2023 Completed Startup
2. Accelerator/Incubator 23-Jul-2023 Completed Startup
1. Seed Round 31-May-2022 Completed Startup
To view BnJ Biopharma’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

BnJ Biopharma Patents

BnJ Biopharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026226000-A1 Compounds with proteolytic activity against kras g12d mutant protein and medical uses thereof Pending 23-Apr-2025
WO-2026225876-A1 Crbn protac compounds having egfr mutant protein degradation activity and use thereof Pending 23-Apr-2025
WO-2026226002-A1 Crbn protac compounds with egfr mutant proteolytic activity and medical uses thereof Pending 23-Apr-2025
WO-2026226001-A1 Vhl protac compounds having egfr mutant protein degradation activity and medical uses thereof Pending 23-Apr-2025

BnJ Biopharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BnJ Biopharma Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
MUST Accelerator Accelerator/Incubator Minority
The Invention Lab Accelerator/Incubator Minority
Tech Incubator Program for Startup Accelerator/Incubator
Bigbang Angels Venture Capital Minority
Innocube Accelerator/Incubator Minority
To view BnJ Biopharma’s complete investors history, request access »

BnJ Biopharma FAQs

  • When was BnJ Biopharma founded?

    BnJ Biopharma was founded in 2021.

  • Where is BnJ Biopharma headquartered?

    BnJ Biopharma is headquartered in Incheon, South Korea.

  • What is the size of BnJ Biopharma?

    BnJ Biopharma has 16 total employees.

  • What industry is BnJ Biopharma in?

    BnJ Biopharma’s primary industry is Drug Discovery.

  • Is BnJ Biopharma a private or public company?

    BnJ Biopharma is a Private company.

  • What is BnJ Biopharma’s current revenue?

    The current revenue for BnJ Biopharma is .

  • How much funding has BnJ Biopharma raised over time?

    BnJ Biopharma has raised $386K.

  • Who are BnJ Biopharma’s investors?

    MUST Accelerator, The Invention Lab, Tech Incubator Program for Startup, Bigbang Angels, and Innocube have invested in BnJ Biopharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process